Publicité
Publicité
BBLG
Bone Biologics Corp Common Stock
1.60
USDSponsorisé
+0.05
+3.55%
09 janv., 15:52 UTC -5
Fermé
Après-marché
1.61
+0.01
+0.62%
BBLG Rapports sur les bénéfices
Ratio de surprise positive
BBLG a dépassé 12 des 15 dernières estimations.
80%
Prochain rapport
Date du prochain rapport
24 févr. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.34
Variation implicite de Q3 25 (Revenue/ EPS)
--
/-8.11%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-90.76%
Bone Biologics Corp Common Stock earnings per share and revenue
On 14 nov. 2025, BBLG reported earnings of -0.37 USD per share (EPS) for Q3 25, beating the estimate of -1.25 USD, resulting in a 70.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an baisse of -8.11% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
What were Bone Biologics Corp Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bone Biologics Corp Common Stock reported EPS of -$0.37, beating estimates by 70.51%, and revenue of $0.00, 0% as expectations.
How did the market react to Bone Biologics Corp Common Stock's Q3 2025 earnings?
The stock price moved up 1.69%, changed from $1.60 before the earnings release to $1.63 the day after.
When is Bone Biologics Corp Common Stock expected to report next?
The next earning report is scheduled for 24 févr. 2026.
What are the forecasts for Bone Biologics Corp Common Stock's next earnings report?
Based on 3
analystes, Bone Biologics Corp Common Stock is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité